Can Gilead (GILD) Stock Continue Rising in 2027?

Gilead Sciences, Inc. (NASDAQ:GILD) shares are up more than 24% this year, ahead of the S&P 500’s 14%. Gilead makes HIV, liver disease and cancer drugs. The stock is part of our coverage of the 8 best-performing stock picks by Claude AI in 2026. Why Gilead Stock Is Up Gilead Q2 sales rose 10% year […]